Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 47

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen

Leone, Mara, Romeijn, Stefan, Slütter, Bram, O’Mahony, Conor, Kersten, Gideon, Bouwstra, Joke A.·2020·European Journal of Pharmaceutical Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejps.2020.105269

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. Hirobe, 2015, Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch, Biomaterials, 57, 50, 10.1016/j.biomaterials.2015.04.007 · DOI · Paper page
  2. Arya, 2017, Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects, Biomaterials, 128, 1, 10.1016/j.biomaterials.2017.02.040 · DOI · Paper page
  3. Leone, 2017, Dissolving microneedle patches for dermal vaccination, Pharm. Res., 34, 2223, 10.1007/s11095-017-2223-2 · DOI
  4. van der Maaden, 2012, Microneedle technologies for (trans)dermal drug and vaccine delivery, J. Control. Release, 161, 645, 10.1016/j.jconrel.2012.01.042 · DOI · Paper page
  5. Larraneta, 2016, Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development, Mat. Sci. Eng. R., 104, 1, 10.1016/j.mser.2016.03.001 · DOI · Paper page
  6. Larraneta, 2016, Microneedles: a new frontier in nanomedicine delivery, Pharm. Res., 33, 1055, 10.1007/s11095-016-1885-5 · DOI · Paper page
  7. Tuan-Mahmood, 2013, Microneedles for intradermal and transdermal drug delivery, Eur. J. Pharm. Sci., 50, 623, 10.1016/j.ejps.2013.05.005 · DOI · Paper page
  8. van der Maaden, 2015, Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays, Drug Deliv. Transl. Re, 5, 397, 10.1007/s13346-015-0238-y · DOI
  9. Hirobe, 2013, Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device, Pharm. Res-Dordr., 30, 2664, 10.1007/s11095-013-1092-6 · DOI
  10. Leone, 2019, Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: formulation, physicochemical characterization and immunogenicity assessment, Eur. J. Pharm. Biopharm., 134, 49, 10.1016/j.ejpb.2018.11.013 · DOI
  11. Matsuo, 2014, Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza (vol 160, pg 495, 2012), J. Control. Release, 184, 18, 10.1016/j.jconrel.2014.04.001 · doi:10.1016/j.jconrel.2014.04.001
  12. Matsuo, 2014, A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens (vol 161, pg 10, 2012), J. Control. Release, 184, 10.1016/j.jconrel.2014.04.002 · doi:10.1016/j.jconrel.2014.04.002
  13. Zhu, 2016, Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71, J. Control. Release, 243, 291, 10.1016/j.jconrel.2016.10.019 · DOI
  14. Oh, 2010, Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives, J. Control. Release, 141, 2, 10.1016/j.jconrel.2009.09.010 · DOI · Paper page
  15. Ito, 2011, Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats, Drug Dev. Ind. Pharm., 37, 1387, 10.3109/03639045.2011.576426 · DOI
  16. Liu, 2012, The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin, J. Control. Release, 161, 933, 10.1016/j.jconrel.2012.05.030 · DOI · Paper page
  17. Liu, 2016, Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid, Mol. Pharm., 13, 272, 10.1021/acs.molpharmaceut.5b00765 · DOI
  18. Noble, 2002, Hyaluronan and its catabolic products in tissue injury and repair, Matrix Biol., 21, 25, 10.1016/S0945-053X(01)00184-6 · DOI · Paper page
  19. Termeer, 2000, Oligosaccharides of hyaluronan are potent activators of dendritic cells, J. Immunol., 165, 1863, 10.4049/jimmunol.165.4.1863 · DOI · Paper page
  20. Agren, 1997, Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture, Free Radic. Biol. Med., 23, 996, 10.1016/S0891-5849(97)00098-1 · DOI
  21. Noble, 1996, Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages, J. Exp. Med., 183, 2373, 10.1084/jem.183.5.2373 · DOI · Paper page
  22. Hart, 1997, Dendritic cells: unique leukocyte populations which control the primary immune response, Blood, 90, 3245, 10.1182/blood.V90.9.3245 · DOI · Paper page
  23. Lesley, 1994, Hyaluronan-Binding function of Cd44 is transiently activated on T-Cells during an in-Vivo immune-response, J. Exp. Med., 180, 383, 10.1084/jem.180.1.383 · DOI
  24. Mizrahy, 2011, Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response, J. Control. Release, 156, 231, 10.1016/j.jconrel.2011.06.031 · DOI · Paper page
  25. Termeer, 2003, Hyaluronan – magic glue for the regulation of the immune response?, Trends Immunol., 24, 112, 10.1016/S1471-4906(03)00029-2 · DOI
  26. Kono, 2008, How dying cells alert the immune system to danger, Nature Rev. Immunol., 8, 279, 10.1038/nri2215 · DOI · Paper page
  27. Leone M., M.I. Priester, S. Romeijn, M.R. Nejadnik, J. Monkare, C. O'Mahony, W. Jiskoot, G. Kersten, J. Bouwstra. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: formulation, physicochemical characterization and immunogenicity assessment. In.(Manuscript submitted for pubblication); 2018. · DOI
  28. Wilke, 2006, The evolution from convex corner undercut towards microneedle formation: theory and experimental verification, J. Micromech. Microeng., 16, 808, 10.1088/0960-1317/16/4/018 · DOI
  29. Schipper, 2016, Determination of depth-dependent intradermal immunogenicity of adjuvanted inactivated polio vaccine delivered by microinjections via hollow microneedles, Pharm. Res., 33, 2269, 10.1007/s11095-016-1965-6 · DOI
  30. van der Maaden, 2014, Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats, Pharm. Res., 31, 1846
  31. Leone, 2018, Universal applicator for digitally-controlled pressing force and impact velocity insertion of microneedles into skin, Pharmaceutics, 10, 10.3390/pharmaceutics10040211 · doi:10.3390/pharmaceutics10040211
  32. van der Maaden, 2014, Impact-insertion applicator improves reliability of skin penetration by solid microneedle arrays, AAPS J., 16, 681, 10.1208/s12248-014-9606-7 · doi:10.1208/s12248-014-9606-7
  33. D'Agostino, 2017, Is molecular size a discriminating factor in hyaluronan interaction with human cells?, Carbohyd. Polym., 157, 21, 10.1016/j.carbpol.2016.07.125 · DOI
  34. Rayahin, 2015, High and low molecular weight hyaluronic acid differentially influence macrophage activation, Acs. Biomater. Sci. Eng., 1, 481, 10.1021/acsbiomaterials.5b00181 · DOI · Paper page
  35. Topazio, 2014, Could hyaluronic acid (HA) reduce Bacillus Calmette–Guerin (BCG) local side effects? results of a pilot study, BMC Urol., 14, 10.1186/1471-2490-14-64 · doi:10.1186/1471-2490-14-64
  36. Zamboni, 2018, The potential of hyaluronic acid in immunoprotection and immunomodulation: chemistry, processing and function, Prog. Mater Sci., 97, 97, 10.1016/j.pmatsci.2018.04.003 · DOI · Paper page
  37. Litwiniuk, 2016, Hyaluronic acid in inflammation and tissue regeneration, Wounds, 28, 78
  38. Chanmee, 2016, Hyaluronan: a modulator of the tumor microenvironment, Cancer Lett., 375, 20, 10.1016/j.canlet.2016.02.031 · DOI · Paper page
  39. Bollyky, 2007, Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells, J. Immunol., 179, 744, 10.4049/jimmunol.179.2.744 · DOI · Paper page
  40. Hsu, 2006, The role of CD4(+)CD25(+) T cells in autoantibody production in murine lupus, Clin. Exp. Immunol., 145, 513, 10.1111/j.1365-2249.2006.03173.x · DOI
  41. Hodge-Dufour, 1997, Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages, J. Immunol., 159, 2492, 10.4049/jimmunol.159.5.2492 · DOI · Paper page
  42. Horton, 1998, Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages, J. Immunol., 160, 3023, 10.4049/jimmunol.160.6.3023 · DOI
  43. McKee, 1996, Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44, J. Clin. Invest., 98, 2403, 10.1172/JCI119054 · DOI · Paper page
  44. Noble, 1993, Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages, J. Clin. Invest., 91, 2368, 10.1172/JCI116469 · DOI · Paper page
  45. Stern, 2006, Hyaluronan fragments: an information-rich system, Eur. J. Cell Biol., 85, 699, 10.1016/j.ejcb.2006.05.009 · DOI · Paper page
  46. Keijzer, 2011, PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity, PLoS ONE, 6, e26684, 10.1371/journal.pone.0026684 · DOI
  47. Benne, 2018, Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice, J. Control. Release, 291, 135, 10.1016/j.jconrel.2018.10.028 · DOI
  48. Monkare, 2015, IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery, J. Control. Release, 218, 53, 10.1016/j.jconrel.2015.10.002 · doi:10.1016/j.jconrel.2015.10.002
  49. Passi, 2019, Hyaluronan as tunable drug delivery system, Adv. Drug Deliver Rev., 146, 83, 10.1016/j.addr.2019.08.006 · DOI

Cited by

See all 47

Metadata

Authors
Leone, M., Romeijn, S., Slütter, B., O’Mahony, C., Kersten, G., & Bouwstra, J. A.
Venue
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2020-04
Volume
146
Pages
105269
ISSN
0928-0987
Cited by
47
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen. https://app.cochat.ai/papers/10.1016/j.ejps.2020.105269
The paper
Leone, M., Romeijn, S., Slütter, B., O’Mahony, C., Kersten, G., & Bouwstra, J. A. (2020). Hyaluronan molecular weight: Effects on dissolution time of dissolving microneedles in the skin and on immunogenicity of antigen. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2020.105269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.